Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers (NAICS 459991)

An investor's primer — United States

1. Overview

This is the industry of specialty stores that sell tobacco, nicotine, and — since a 2022 reclassification — state-legal cannabis to consumers: the corner smoke shop, the strip-mall vape store, the neighborhood tobacconist, the online cigar warehouse, the head shop, and the licensed marijuana dispensary. NAICS (North American Industry Classification System, the U.S. government's standard scheme for grouping businesses) code 459991 covers retailers whose primary business is cigarettes, cigars, pipe and loose tobacco, e-cigarettes and e-liquids, nicotine pouches, smoking accessories — and, under the 2022 revision, medical and recreational marijuana stores, which were folded in from the old dispensary code (453998).[1]

That makes 459991 two quite different retail worlds under one label: a fragmented, Main-Street tobacco/vape trade, and a fast-growing but federally-illegal cannabis-retail business. For an investor, the two behave very differently.

• Public-market investors have almost no pure way into the tobacco/vape side — there is no scaled, listed U.S. company whose core business is running smoke or vape shops. The closest listed pure-plays that actually operate in-scope stores are the cannabis dispensary chains, and they trade only over-the-counter because federal law keeps them off the major exchanges (Section 4). Broader exposure comes indirectly, through the convenience-store chains and tobacco manufacturers that sit on either side of these retailers.
• Private investors are the natural owners of the tobacco/vape side: buying, building, or franchising a smoke or vape shop is a classic small-business play — low entry cost, high gross margins, real regulatory and reputational risk, and valuations set on the open small-business market.

The most durable investment theses here come from local consolidation, compliance discipline, pricing, and product-mix shift — not from broad category-volume growth, which is flat to declining on the tobacco side.

2. What it is, and how it's structured

In scope: establishments that mainly retail tobacco and smoking supplies — tobacco stores, cigar shops and lounges that sell product, vape and e-cigarette shops, smokers'-supply and head shops, dedicated online/mail-order tobacco and cigar sellers, and — importantly — medical and recreational marijuana (cannabis) stores.[1] The 2022 NAICS overhaul eliminated the old separate "nonstore retailers" sector, so pure online tobacco/vape/cigar sellers now generally map here too, alongside their brick-and-mortar peers.[2]

Explicitly out of scope — a crucial caveat: the code does not include the channels where most nicotine is actually sold. Convenience stores and gas-station marts are classified under NAICS 445131 (Convenience Retailers) and 457110 (Gasoline Stations with Convenience Stores) — they sell enormous volumes of tobacco but are classified by their convenience or fuel activity. Also excluded: 424940 (Tobacco and Tobacco Product Merchant Wholesalers), 312230 (Tobacco Manufacturing), and 459999 (Other Miscellaneous Retailers). So 459991 is the specialist channel only, sitting alongside a much larger mass-retail tobacco channel it excludes.[1][2]

Ownership mix: overwhelmingly independent small businesses. Federal data show 21,082 establishments run by roughly 19,453 firms — about 1.08 stores per firm, i.e. the typical owner runs a single location.[4][5] The average store employs about 3.6 people.[4] The exceptions sit at the two ends: loose banner networks and small regional chains in the tobacco/vape segment (Section 4), and the vertically integrated, multi-state cannabis operators — but no tobacco/vape operator is anywhere near national scale.

3. How big it is

Our ground-truth federal figures for NAICS 459991:

(County Business Patterns, or CBP, is the Census Bureau's annual establishment/employment/payroll count; the Small Business Administration, or SBA, sets the receipts ceiling below which a firm qualifies as "small.")

A few things these numbers imply. Average sales per firm work out to roughly $1.6 million (2022 receipts ÷ firms) — pulled up by large online cigar retailers, multi-store operators, and higher-ticket cannabis dispensaries; the median neighborhood shop is far smaller. Average pay is about $28,300 per worker per year (payroll ÷ employment) — low-wage, part-time-heavy retail. Payroll is a small fraction of sales, consistent with a lean, few-employees-per-store model.[4][5]

The undercount to keep in mind. These federal series are establishment- and payroll-oriented, so they under-count in three ways:

1. The mass channel is excluded. Convenience stores alone account for roughly 87% of U.S. tobacco retail dollars,[23] so if you are sizing "the U.S. tobacco retail market," this code understates it by several times — it measures smoke, vape, and cannabis shops, not the whole trade.
2. The long tail is thin data. Tiny sole proprietors, nonemployer storefronts, and short-lived vape shops are easy to miss.[3]
3. Cannabis is federally illegal, so state-legal dispensaries — though nominally in-scope — are almost certainly under-captured in a federal survey, and any illegal or unreported commerce is outside the count entirely.[3]

The federal file also does not provide industry-wide same-store sales, product-category revenue, margins, inventory turns, online-sales share, closures, or private-company profitability. Those figures are not available here and should not be inferred.

For scale on the fastest-growing tobacco sub-segment, independent research houses put the U.S. vape-shop count near 10,500 in 2024 (up from ~7,900 in 2022), with vaping-category revenue around $8 billion.[7][8]

4. The investable universe

The honest headline: there is no scaled, publicly traded, pure-play U.S. tobacco or vape retailer. The only listed companies whose core business is actually operating in-scope 459991 stores are the cannabis dispensary chains — and they carry their own heavy federal-legal risk. Everyone else is either a private owner or an adjacent business. Think of the public universe in three buckets.

A. Direct in-scope public exposure — cannabis multi-state operators (MSOs). These run licensed dispensaries, which fall inside 459991. Because cannabis is federally illegal, they cannot list on the NYSE or Nasdaq; they trade over-the-counter (OTC) in the U.S. and on the Canadian Securities Exchange (CSE). That means thinner liquidity, custody friction, and real regulatory overhang.

B. Adjacent public exposure — where tobacco economics actually show up. These are not in 459991, but they are the investable, at-scale face of tobacco retailing.

C. Private owners — the real universe of the tobacco/vape side. Tens of thousands of independent smoke and vape shops; regional cigar-lounge and tobacconist groups; and a few scaled private names:

• Smoker Friendly International — a banner-style network reporting 800+ independently owned affiliated stores, with its own SF-brand products.[46]
• Wild Bill's Tobacco — a private Michigan-based chain reporting 170+ locations across Michigan, Ohio, and Indiana (a company marketing claim, not audited data).[45]
• Large online cigar retailers such as Famous Smoke Shop and Cigars International (owned by cigar manufacturers/holding companies), which run warehouse-scale mail-order operations.
• QuikTrip and other large private c-store operators are an important adjacent tobacco channel.[47]

One caution on thematic micro-caps: treat "vape" tickers skeptically. CEA Industries once traded as ticker VAPE and owned a Canadian vape chain (Fat Panda), but rebranded to BNC in 2025 and pivoted away from vape retail entirely — a reminder that tiny thematic tickers often don't do what their name implies.[49]

5. How the money works

The basic model is inventory-led retail: sales, less product cost, supplier rebates, labor, rent, payment-card fees, shrink, taxes, and compliance costs. Owners make money on gross margin per transaction × traffic × repeat visits, against low fixed costs. The economics differ sharply by product:

• Combustible cigarettes are a traffic product, not a profit product: heavily taxed, price-transparent, low-margin (mid-single-digit retail margins). Smoke shops that lean on cigarettes typically run overall net margins around 4–6%.[50]
• Vapes and e-liquids are where specialty stores earn their keep. Hardware and accessories carry 30–50% margins, and house or bottled e-liquid can be marked up several times over. Vape-focused shops report product margins near 37% and net margins commonly in the 7–20% range.[51]
• Premium cigars and lounges monetize experience and dwell time — high per-unit prices, memberships, lockers, and attached bar/food revenue. The U.S. cigar-lounge segment is roughly a $1.2 billion business growing ~5% a year and is deeply fragmented (no operator above ~5% share).[29]
• Nicotine pouches (Zyn, on!, Velo) are the current growth engine across every channel — small, high-frequency repeat purchases with solid margins.[12][31]
• Cannabis carries higher tickets and more differentiation, but also the heaviest authorization, licensing, banking, and tax burden — including federal tax code Section 280E, which historically barred cannabis sellers from deducting normal business expenses.

Because most tobacco/vape operators are single stores, the practical levers are the classic retail ones. Useful operating measures include same-store sales (SSS), transaction count and average ticket, gross margin and merchandise contribution, supplier rebates, inventory turns and aged inventory, labor/rent/compliance cost per store, and store-level cash flow and payback. Public filings show why cross-company comparison needs care: Casey's reports tobacco/nicotine at ~9% of total revenue, ARKO reports tobacco at ~38% of merchandise revenue, and Murphy USA reported 2025 nicotine same-store sales roughly flat with nicotine margins up ~5% — different denominators, not industry averages.[36][37][38]

For a private buyer, these businesses change hands on the open small-business market at low multiples of owner earnings (seller's discretionary earnings, or SDE — roughly owner take-home plus add-backs), reflecting their size, key-person dependence, and regulatory overhang. The value is in cash flow, not a brand or a moat.

6. What drives demand

• The great substitution. U.S. adult cigarette smoking has collapsed from about 42% in the mid-1960s to roughly 11% recently, and youth cigarette use is at record lows.[11] Cigarette unit sales keep falling year after year.[9] Demand is not disappearing — it is migrating to vapes, pouches, and heat-not-burn products, which is exactly what specialty retailers are best positioned to sell. Adult e-cigarette use rose from 4.5% in 2019 to 6.5% in 2023 (Centers for Disease Control and Prevention, or CDC).[10]
• Nicotine pouches are booming. Monthly pouch sales rose more than 250% between early 2023 and mid-2025; the category jumped ~59% in convenience stores in 2024 and now makes up roughly half of the U.S. oral-tobacco market.[12][31] In 2026 the FDA authorized Philip Morris to market Zyn as lower-risk than cigarettes — legitimizing the fastest-growing product on the shelf.[13]
• Vaping demand is real but policy-gated. Category revenue keeps growing, but what consumers most want (flavored disposables) is largely unauthorized, so demand sloshes between legal and illicit product depending on enforcement (Section 7).[7][19]
• State cannabis markets. Where legal, adult-use and medical cannabis is a large, fast-adding demand pool feeding the in-scope dispensary side of the code.
• Age, price, and income. Federal law sets the minimum purchase age at 21, and the tobacco customer base skews lower-income, making the category sensitive to excise taxes and price. Online purchasing and delivery can also erode the physical store's advantage.[25]

7. Regulation

Regulation is the single biggest force acting on this industry, and it cuts in several directions.

• FDA product authorization (PMTA). The Food and Drug Administration (FDA) requires every e-cigarette to clear a Premarket Tobacco Product Application (PMTA) proving it is "appropriate for the protection of public health." The bar is high: the FDA has authorized only a few dozen e-cigarette products (on the order of 40), and only a handful are disposables — none in the fruit and sweet flavors that dominate youth use and the illicit market. Authorization is not the same as "FDA approved" or "safe."[14][15] The Supreme Court in 2025 backed the FDA's denials of flavored-vape applications, cementing the framework.[16]
• Enforcement vs. an illicit flood. Because flavored disposables are wildly popular but almost entirely unauthorized, a gray market has exploded. Roughly $2.4 billion of unauthorized flavored disposables — mostly Chinese brands like Elf Bar and Geek Bar — were sold in the U.S. in 2024, an estimated 35% of tracked e-cig sales. The FDA has issued 200+ warning letters since mid-2024, but enforcement is patchy, and compliant retailers compete against shops that stock illegal product.[17][18][19]
• Flavor and menthol rules. The federal menthol-cigarette and flavored-cigar bans were formally withdrawn in early 2025, removing a major overhang for cigarette-heavy retailers.[20][21] But state and local flavor bans persist — Massachusetts and California prohibit flavored tobacco outright — so a store's legal assortment depends on its ZIP code.[21][28]
• Age verification and retailer rules. The federal minimum sales age is 21 ("T21"), and retailers must check photo ID for anyone under 30 buying covered tobacco, including e-cigarettes. The FDA also restricts vending machines, free samples, self-service displays, packaging, and warnings, and runs compliance inspections; repeat violations bring civil penalties or no-tobacco-sale orders.[25][26][27]
• Taxes and licensing. Excise taxes are the operator's chief financial worry: they raise shelf prices, depress volume, and vary enormously by state, with many states weighing further hikes.[24] As of mid-2024, 40+ states plus D.C. require a tobacco-retail license, with fees ranging from about $6 (New Hampshire) to $800 (Connecticut).[22]
• Online shipping (PACT Act). The Prevent All Cigarette Trafficking (PACT) Act, extended to vaping products, restricts mail shipping and imposes registration and age-verification duties — a direct hit to the online sellers inside this code.[16]
• Cannabis is a separate regulatory world. In April 2026 the Department of Justice (DOJ) and Drug Enforcement Administration (DEA) moved qualifying state-licensed medical-marijuana products to Schedule III and opened a broader rescheduling process — a meaningful shift (it could ease the 280E tax burden and, over time, banking), but not nationwide legalization. Cannabis retailers still operate under state licensing, local zoning, and a federal-state legal conflict.[44]

8. Competitive dynamics and consolidation

This is one of the least concentrated retail industries in the economy. The four largest firms capture just 6.1% of sales (CR4), the top eight 8.5% (CR8), the top twenty 12.7% (CR20), and the top fifty only 18.3% (CR50); the Herfindahl-Hirschman Index (HHI, a standard concentration measure where higher = more concentrated) sits at 14.6 — essentially "perfectly competitive."[5] There is no dominant chain, no store-level pricing power, and low barriers to opening a shop, though local competition (location, assortment, service, vendor terms, license access) can be fierce.

The competitive pressure comes from outside the code as much as inside it. Convenience stores — with their scale, foot traffic, and ~87% share of tobacco dollars — are the real competition, and they increasingly stock the same vapes and pouches.[23] Within the specialty channel, consolidation is happening at the edges: cigar manufacturers (e.g., Altadis) have converted independent tobacconists into branded lounges,[30] a few regional vape chains and franchises are rolling up single stores, and the cannabis MSOs are consolidating dispensary licenses state by state. The most likely path to scale is a private-equity- or manufacturer-backed roll-up, not an organically grown national tobacco/vape brand — and state-by-state licensing and zoning make a single national operating model genuinely hard.

9. Risks

• Regulatory whiplash. A single FDA decision, state flavor ban, or excise-tax hike can wipe out a store's best-selling category overnight. This is the defining risk.[16][21][24]
• Illicit competition. Legal retailers are undercut by shops selling unauthorized disposables; enforcement is inconsistent.[19]
• Secular decline of cigarettes. The traffic-driving legacy product shrinks every year; stores that don't pivot to vape/pouch/cannabis mix fade with it.[9]
• Inventory obsolescence. Rule changes and product de-authorizations can strand shelf stock.
• Youth-use backlash. Vapes and pouches remain the most-used nicotine products among teens, keeping the category under political and PR pressure and inviting tougher rules.[28]
• Cannabis federal-state conflict. Dispensary owners face banking limits, punitive taxation, restricted financing, and the risk that rescheduling stalls or reverses.[44]
• Small-operator fragility. Thin scale, key-person dependence, rising rents, card-fee and tax pressure, plus cash-handling, shrink, and age-verification exposure push a steady stream of independents out of business.[24]
• Reputational/ESG exclusion. Nicotine and cannabis are screened out of many funds and mandates (ESG = environmental, social, governance investment screens), limiting institutional capital and public-market appetite.
• Poor data visibility. Many operators are small, private, or classified outside the code, so reliable industry-level operating data is scarce.

10. How to invest, and the outlook

Public-market routes (reserve these portfolio caveats for allocation decisions):

• Direct in-scope pure-play — cannabis dispensary operators: Curaleaf (CURLF), Green Thumb (GTBIF), Trulieve (TCNNF), Cresco Labs (CRLBF), Verano (VRNO/VRNOF) — the only listed companies actually running in-scope stores, but OTC-traded, illiquid, and carrying federal-legal and banking risk. Rescheduling is the swing factor.[39][40][41][42][43][44]
• The channel that actually sells tobacco at scale: convenience operators Casey's (CASY), Murphy USA (MUSA), ARKO (ARKO), Alimentation Couche-Tard (ATD) — a different NAICS code, but the investable face of tobacco-retail economics.[36][37][38]
• Closest specialty supplier: Turning Point Brands (TPB) — a small/mid-cap selling the picks-and-shovels (rolling papers, oral tobacco) these stores stock.[32]
• Upstream cash flows and yield: the manufacturers Altria (MO), Philip Morris International (PM), British American Tobacco (BTI) — the sector's hallmark high dividend yields (Altria has historically yielded in the high single digits) and direct exposure to the vape/pouch shift, though they are makers, not retailers.[33][34][35][48]
• Avoid thematically named micro-caps ("vape" tickers) without confirming the underlying business — several have pivoted away from retail entirely.[49]

Private routes — the more natural fit for the tobacco/vape side:

• Buy an existing shop on the small-business market, underwriting on cash flow (SDE), lease terms, license transferability, and product mix.
• Build or franchise a vape/cigar concept, leaning into high-margin e-liquid, pouches, and lounge/experience revenue rather than commodity cigarettes.
• Roll up several independents in a region to gain purchasing, technology, age-verification, and compliance scale — the most credible way to create institutional value here — or invest around the stores in a banner network, distribution, real estate, equipment, or private credit.

Near-term outlook. The demand backdrop favors the modernizing operator: nicotine consumption is stable and shifting toward exactly the high-margin vape and pouch products specialty stores sell best, with pouches now growing fast and newly blessed by the FDA as reduced-risk.[12][13] The swing factor is enforcement: if the FDA and states clamp down hard on unauthorized flavored disposables, compliant retailers gain share and pricing; if enforcement stays porous, the illicit channel keeps siphoning the most-wanted products. The cigarette leg will keep shrinking regardless.[9] On the cannabis side, rescheduling could gradually improve dispensary economics, but federal illegality remains the binding constraint. For public-market investors this is best treated as an indirect, dividend-oriented theme through manufacturers and c-store chains, plus a high-risk, OTC cannabis-retail option; for private investors it is a viable, cash-generative small-business niche — provided you can live with regulation as a permanent, unpredictable partner. Overall, expect returns to come from operational improvement and consolidation, not broad industry growth.

---

Sources

1. U.S. Census Bureau, NAICS 2022 Definition — 459991 (incl. "Marijuana stores, medical or recreational"), 2022. https://www.census.gov/naics/?input=459991&year=2022&details=459991
2. U.S. Census Bureau, 2022 NAICS Manual, 2022. https://www.census.gov/naics/reference_files_tools/2022_NAICS_Manual.pdf
3. U.S. Census Bureau, About the 2022 Economic Census (coverage/undercount), 2022. https://www.census.gov/programs-surveys/economic-census/year/2022/about.html
4. U.S. Census Bureau, County Business Patterns (CBP), NAICS 459991 (establishments, employment, payroll), 2023. https://www.census.gov/programs-surveys/cbp.html
5. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms, NAICS 459991 (receipts, firms, CR4/8/20/50, HHI), 2022. https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
6. U.S. Small Business Administration, Table of Size Standards, 2023. https://www.sba.gov/document/support-table-size-standards
7. IBISWorld, Electronic Cigarette & Vape Shops in the US — Industry Analysis, 2024. https://www.ibisworld.com/united-states/industry/electronic-cigarette-vape-shops/6293/
8. My Delta 8 Store, How Many Vape Shops and Stores Are in the US?, 2026. https://www.mydelta8store.com/number-of-vape-shops-in-the-us/
9. ScienceDirect (Preventive Medicine Reports), Declining cigarette sales and shifts in the US cigarette marketplace, 2016–2024, 2026. https://www.sciencedirect.com/science/article/pii/S2211335526000094
10. Centers for Disease Control and Prevention, Electronic Cigarette Use Among Adults in the United States, 2019–2023, 2025. https://www.cdc.gov/nchs/products/databriefs/db524.htm
11. Psychology Today, Zyn Nicotine Pouch Products Get FDA Approval for Adults (adult smoking-rate decline; youth use), 2025. https://www.psychologytoday.com/us/blog/addiction-outlook/202502/zyn-nicotine-pouch-products-get-fda-approval-for-adults
12. Tobacco Insider, USA: Nicotine Pouches, 2025. https://tobaccoinsider.com/nicotine-pouches-usa/
13. CNBC, FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes, 2026. https://www.cnbc.com/2026/06/30/fda-zyn-philip-morris-nicotine-pouches-cigarettes-trump.html
14. U.S. Food and Drug Administration, E-Cigarettes, "Vapes," and Other ENDS Authorized by the FDA, 2026. https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/e-cigarettes-vapes-and-other-electronic-nicotine-delivery-systems-ends-authorized-fda
15. U.S. Food and Drug Administration, Tobacco Products Marketing Orders (authorization ≠ "approved"/safe), 2026. https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/tobacco-products-marketing-orders
16. E-Liquid Depot, Vaping Legislation 2025: Flavor Bans, PMTA & the PACT Act (2025 Supreme Court ruling; PACT Act; T21), 2025. https://www.eliquid-depot.com/blog/legal/vaping-legislation-2025-flavor-bans-pmta-bills/
17. U.S. Food and Drug Administration, Advisory and Enforcement Actions Against Industry for Unauthorized Tobacco Products, 2024–2025. https://www.fda.gov/tobacco-products/compliance-enforcement-training/advisory-and-enforcement-actions-against-industry-unauthorized-tobacco-products
18. CNBC, China e-cigarette titan behind 'Elf Bar' floods the U.S. with illegal vapes, 2023. https://www.cnbc.com/2023/12/06/china-e-cigarette-titan-behind-elf-bar-floods-the-us-with-illegal-vapes.html
19. Sherwood News, Inside Big Tobacco's knock-off vape nightmare (illicit disposable sales ~$2.4B / share), 2024. https://sherwood.news/business/chinese-illicit-vapes-juul-big-tobacco-problems/
20. The Hill, Trump's FDA officially withdraws long-delayed menthol cigarette ban, 2025. https://thehill.com/policy/healthcare/5105771-trump-fda-menthol-cigarettes-ban/
21. Tobacco Law Blog, FDA Withdraws Proposed Bans on Menthol Cigarettes and Flavored Cigars (and state flavor bans), 2025. https://www.tobaccolawblog.com/2025/02/fda-withdraws-proposed-bans-on-menthol-cigarettes-and-flavored-cigars/
22. ASTHO, Enhancing Tobacco Control through Retailer Licensing Policies (license fees by state), 2024. https://www.astho.org/communications/blog/enhancing-tobacco-control-through-retailer-licensing-policies/
23. Convenience Store News, Data Highlights Important Relationship Between C-stores & Tobacco (~87% channel share), 2023. https://csnews.com/data-highlights-important-relationship-between-c-stores-tobacco
24. CSP Daily News, Convenience retailers are concerned about excise taxes affecting cigarette sales, 2024. https://www.cspdailynews.com/tobacco/convenience-retailers-are-concerned-about-excise-taxes-which-are-affecting-cigarette
25. U.S. Food and Drug Administration, Tobacco 21, 2026. https://www.fda.gov/tobacco-products/retail-sales-tobacco-products/tobacco-21
26. U.S. Food and Drug Administration, Summary of Federal Rules for Tobacco Retailers, 2026. https://www.fda.gov/tobacco-products/retail/summary-federal-rules-tobacco-retailers
27. U.S. Food and Drug Administration, Retail Sales of Tobacco Products (inspections, penalties), 2026. https://www.fda.gov/tobacco-products/compliance-enforcement-training/retail-sales-tobacco-products
28. Centers for Disease Control and Prevention, State System E-Cigarette Fact Sheet, 2024. https://www.cdc.gov/statesystem/factsheets/ecigarette/ECigarette.html
29. IBISWorld, Cigar Lounges in the US — Industry Analysis, 2025. https://www.ibisworld.com/united-states/industry/cigar-lounges/4392/
30. Cigar Aficionado, Lounges of Distinction (Altadis branded-lounge conversions), 2024. https://www.cigaraficionado.com/article/lounges-of-distinction-15954
31. C-Store Dive, 3 charts outlining the growing smokeless nicotine market, 2025. https://www.cstoredive.com/news/3-charts-dissecting-the-growing-smokeless-nicotine-market/823070/
32. Turning Point Brands, Form 10-K for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1290677/000143774926006405/tpb20251231_10k.htm
33. Altria Group, Form 10-K for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/764180/000076418026000017/mo-20251231.htm
34. Philip Morris International, Form 10-K for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1413329/000162828026005939/pm-20251231.htm
35. British American Tobacco, Form 20-F for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1303523/000130352326000017/bti-20251231.htm
36. Casey's General Stores, Form 10-K for the Year Ended April 30, 2025 (tobacco/nicotine ~9% of revenue), 2025. https://www.sec.gov/Archives/edgar/data/726958/000072695825000065/casy-20250430.htm
37. Murphy USA, Form 10-K for the Year Ended December 31, 2025 (nicotine SSS/margins), 2026. https://www.sec.gov/Archives/edgar/data/1573516/000157351626000090/musa-20251231.htm
38. ARKO Corp., Form 10-K for the Year Ended December 31, 2025 (tobacco ~38% of merchandise revenue), 2026. https://www.sec.gov/Archives/edgar/data/1823794/000119312526071464/arko-20251231.htm
39. Curaleaf Holdings, Annual Report for the Year Ended December 31, 2025 (~159 dispensaries, 15 states), 2026. https://www.sec.gov/Archives/edgar/data/1756770/000175677026000019/curlf-20251231_d2.htm
40. Green Thumb Industries, Form 10-K for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1795139/000119312526071672/gtbif-20251231.htm
41. Trulieve Cannabis, Form 10-K for the Year Ended December 31, 2025 (200+ retail locations), 2026. https://www.sec.gov/Archives/edgar/data/1754195/000175419526000019/tcnnf-20251231.htm
42. Cresco Labs, Annual Report for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1832928/000183292826000005/crlbf-20251231.htm
43. Verano Holdings, Form 10-K for the Year Ended December 31, 2025, 2026. https://www.sec.gov/Archives/edgar/data/1848416/000162828026017011/vrnof-20251231.htm
44. U.S. Department of Justice, Justice Department Places FDA-Approved Marijuana Products and Qualifying State-Licensed Marijuana Products in Schedule III, 2026. https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana
45. Wild Bill's Tobacco, About Wild Bill's Tobacco (170+ locations; company claim), 2026. https://wildbillstobacco.com/about/
46. Smoker Friendly International, Smoker Friendly (800+ affiliated stores), 2026. https://smokerfriendly.com/
47. QuikTrip, About Us, 2026. https://www.quiktrip.com/about-us/
48. The Motley Fool, Best Tobacco Stocks for 2026 and How to Invest (dividend yields), 2026. https://www.fool.com/investing/stock-market/market-sectors/consumer-staples/tobacco-stocks/
49. StockTitan, CEA Industries (VAPE → BNC) (Fat Panda vape retail; ticker change/pivot), 2025. https://www.stocktitan.net/news/VAPE/
50. POS Nation, How Profitable Is a Smoke Shop? (net margins 4–6%), 2025. https://www.posnation.com/blog/how-profitable-is-a-smoke-shop
51. Cigars POS, Smoke Shop Profit Margins (vape ~37%; e-liquid markups), 2025. https://www.cigarspos.com/blog/smoke-shop-profit-margin